Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arzneiwerk AG VIDAFRA:TLIK +0.98%40 PS Ratio is 51.50 as of Aug. 30, 2026, which is 5379% above its 10-year median of 0.94. GuruFocus rates FRA:TLIK with a GF Score™ of 40/100. The stock has 7 warning signs investors should review. Among 119 Medical Distribution companies, Arzneiwerk AG VIDA ranks worse than 100% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Arzneiwerk AG VIDA's share price is €0.206.
Arzneiwerk AG VIDA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00. Hence, Arzneiwerk AG VIDA's PS Ratio for today is 51.50.
The historical rank and industry rank for Arzneiwerk AG VIDA's PS Ratio or its related term are showing as below:
FRA:TLIK'
s PS Ratio Range Over the Past 10 Years
Min: 0.06 Med: 0.94 Max: 97
Current: 51.5
During the past 13 years, Arzneiwerk AG VIDA's highest PS Ratio was 97.00. The lowest was 0.06. And the median was 0.94.
FRA:TLIK's PS Ratio is ranked worse than 100% of 119
companies
in the Medical Distribution industry
Industry Median: 0.43
vs FRA:TLIK: 51.50
Arzneiwerk AG VIDA revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Arzneiwerk AG VIDA was -99.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -68.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -55.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -39.00% per year.
During the past 13 years, Arzneiwerk AG VIDA's highest 3-Year average Revenue per Share Growth Rate was -2.10% per year. The lowest was -68.40% per year. And the median was -15.65% per year.
Arzneiwerk AG VIDA (FRA:TLIK) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Arzneiwerk AG VIDA PS Ratio Related Terms
Arzneiwerk AG VIDA PS Ratio Historical Data
* Premium members only.
The historical data trend for Arzneiwerk AG VIDA's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Arzneiwerk AG VIDA's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arzneiwerk AG VIDA PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arzneiwerk AG VIDA's PS Ratio distribution charts can be found below:
* The bar in red indicates where Arzneiwerk AG VIDA's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Arzneiwerk AG VIDA's Share Price of today is €0.206. Arzneiwerk AG VIDA's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Arzneiwerk AG VIDA (FRA:TLIK) has a PS Ratio of 51.50 as of Aug. 30, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Arzneiwerk AG VIDA and its competitors. This is 5379% above median its historical median of 0.94. Over the past decade, Arzneiwerk AG VIDA's PS Ratio has ranged from 0.06 to 97.00. According to the industry distribution chart, Arzneiwerk AG VIDA ranks #119 out of 119 companies in the Medical Distribution industry.
Is Arzneiwerk AG VIDA's PS Ratio too high?
Arzneiwerk AG VIDA's current PS Ratio of 51.50 is 5379% above median its 10-year median of 0.94. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 97.00. The Medical Distribution industry median PS Ratio is 0.43. Arzneiwerk AG VIDA's value of 51.50 is 11876.7% above this industry median. Based on the distribution chart, Arzneiwerk AG VIDA ranks #119 out of 119 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Arzneiwerk AG VIDA has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Arzneiwerk AG VIDA's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Arzneiwerk AG VIDA ranks #119 out of 119 companies for PS Ratio. This places Arzneiwerk AG VIDA in the lower half of its industry. The industry median PS Ratio is 0.43. Arzneiwerk AG VIDA's value of 51.50 is 11876.7% above this benchmark. Historically, Arzneiwerk AG VIDA's own PS Ratio has ranged from 0.06 to 97.00 over the past decade. While the company's 10-year median is 0.94 vs. the industry median of 0.43, Arzneiwerk AG VIDA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.43, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arzneiwerk AG VIDA's current PS Ratio of 51.50 is 11876.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Arzneiwerk AG VIDA and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arzneiwerk AG VIDA's current PS Ratio is 51.50, which is 5379% above median its own 10-year median of 0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arzneiwerk AG VIDA stock overvalued right now?
Arzneiwerk AG VIDA (FRA:TLIK) has a current PS Ratio of 51.50. The current PS Ratio is 51.50, which is 5379% above median its 10-year median of 0.94 and 11876.7% above the Medical Distribution industry median of 0.43. Arzneiwerk AG VIDA's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Arzneiwerk AG VIDA (FRA:TLIK), the current PS Ratio is 51.50 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe.
40GF Score
Get the complete analysis for FRA:TLIK
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TLIK has been successfully added to your 
